Not approved fordiagnostic, therapeutic, or medical applications
Third-party Certificates of Analysis (COAs) reduce but do not eliminate this risk
And shipping came in 2 days excellent product, felt immediate results
MHRA Borderline Guidance MHRA guidance updated on 2 July 2026 explains that classification can consider pharmacological properties, explicit and implied claims, intended purpose, packaging, websites, social-media content and customer reviews
My work covers both print and digital design, including infographics , leaflets , brochures , magazines , website design , and HTML email campaigns